Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


23.10.2017

1 Am J Gastroenterol
1 Am J Pathol
1 Anticancer Res
1 BMC Cancer
1 BMC Gastroenterol
1 Cancer
19 Dig Dis
3 Dig Dis Sci
1 Endoscopy
3 Gastroenterology
2 Hepatology
1 Indian J Gastroenterol
1 Int J Cancer
1 J Gastroenterol
1 J Hepatol
1 J Pediatr
28 PLoS One
1 Radiology
4 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. PRICE JC, Tien PC
    Editorial: Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression?
    Am J Gastroenterol. 2017;112:1506-1507.
    PubMed     Text format     Abstract available


    Am J Pathol

  2. LABGAA I, Stueck A, Ward SC
    Lymphoepithelioma-Like Carcinoma in Liver.
    Am J Pathol. 2017;187:1438-1444.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. KISHIMOTO S, Yasuda M, Fukushima S
    Changes in the Expression of Various Transporters as Influencing Factors of Resistance to Cisplatin.
    Anticancer Res. 2017;37:5477-5484.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. DAMM R, Seidensticker R, Ulrich G, Breier L, et al
    Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system.
    BMC Cancer. 2016;16:509.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  5. USUI S, Ebinuma H, Chu PS, Nakamoto N, et al
    Detection of bacterial DNA by in situ hybridization in patients with decompensated liver cirrhosis.
    BMC Gastroenterol. 2017;17:106.
    PubMed     Text format     Abstract available


    Cancer

  6. PRINTZ C
    Cancer mortality rates vary among specific Asian American ethnic groups.
    Cancer. 2017;123:11.
    PubMed     Text format    


    Dig Dis

  7. ISHIKAWA T, Imai M, Owaki T, Sato H, et al
    Hemodynamic Changes on Cone-Beam Computed Tomography during Balloon-Occluded Transcatheter Arterial Chemoembolization Using Miriplatin for Hepatocellular Carcinoma: A Preliminary Study.
    Dig Dis. 2017;35:598-601.
    PubMed     Text format     Abstract available

  8. ARIZUMI T, Minami T, Chishina H, Kono M, et al
    Time to Transcatheter Arterial Chemoembolization Refractoriness in Patients with Hepatocellular Carcinoma in Kinki Criteria Stages B1 and B2.
    Dig Dis. 2017;35:589-597.
    PubMed     Text format     Abstract available

  9. ARIZUMI T, Minami T, Chishina H, Kono M, et al
    Impact of Tumor Factors on Survival in Patients with Hepatocellular Carcinoma Classified Based on Kinki Criteria Stage B2.
    Dig Dis. 2017;35:583-588.
    PubMed     Text format     Abstract available

  10. IWAMOTO T, Imai Y, Igura T, Kogita S, et al
    Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellula
    Dig Dis. 2017;35:574-582.
    PubMed     Text format     Abstract available

  11. IDA H, Hagiwara S, Kono M, Minami T, et al
    Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Daclatasvir and Asunaprevir in Patients with Chronic Hepatitis C Virus Infection.
    Dig Dis. 2017;35:565-573.
    PubMed     Text format     Abstract available

  12. UMEHARA Y, Hagiwara S, Nishida N, Sakurai T, et al
    Hepatocarcinogenesis Is Associated with Serum Albumin Levels after Sustained Virological Responses with Interferon-Based Therapy in Patients with Hepatitis C.
    Dig Dis. 2017;35:548-555.
    PubMed     Text format     Abstract available

  13. KOBAYASHI N, Kumada T, Toyoda H, Tada T, et al
    Ability of Cytokeratin-18 Fragments and FIB-4 Index to Diagnose Overall and Mild Fibrosis Nonalcoholic Steatohepatitis in Japanese Nonalcoholic Fatty Liver Disease Patients.
    Dig Dis. 2017;35:521-530.
    PubMed     Text format     Abstract available

  14. KITAHATA S, Hiraoka A, Kudo M, Murakami T, et al
    Abdominal Ultrasound Findings of Tumor-Forming Hepatic Malignant Lymphoma.
    Dig Dis. 2017;35:498-505.
    PubMed     Text format     Abstract available

  15. UESHIMA K, Nishida N, Kudo M
    Sorafenib-Regorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma: A Single-Institute Experience.
    Dig Dis. 2017;35:611-617.
    PubMed     Text format     Abstract available

  16. NISHIDA N, Kudo M
    Role of Immune Checkpoint Blockade in the Treatment for Human Hepatocellular Carcinoma.
    Dig Dis. 2017;35:618-622.
    PubMed     Text format     Abstract available

  17. HIRAOKA A, Kumada T, Kudo M, Hirooka M, et al
    Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.
    Dig Dis. 2017;35:602-610.
    PubMed     Text format     Abstract available

  18. NEVENS F
    Novel Approaches to Reducing the Risk of Variceal Hemorrhage.
    Dig Dis. 2017;35:397-401.
    PubMed     Text format     Abstract available

  19. ROWE IA
    Lessons from Epidemiology: The Burden of Liver Disease.
    Dig Dis. 2017;35:304-309.
    PubMed     Text format     Abstract available

  20. TOWNSEND SA, Newsome PN
    The Role of a Dedicated Non-Alcoholic Fatty Liver Disease Clinic in 2016.
    Dig Dis. 2017;35:371-376.
    PubMed     Text format     Abstract available

  21. CHUNG BK, Karlsen TH
    Genetic Discoveries Highlight Environmental Factors as Key Drivers of Liver Disease.
    Dig Dis. 2017;35:323-333.
    PubMed     Text format     Abstract available

  22. WONG LL, Hegade VS, Jones DEJ
    What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis?
    Dig Dis. 2017;35:359-366.
    PubMed     Text format     Abstract available

  23. THORGEIRSSON SS
    Stemness in Liver Cancer.
    Dig Dis. 2017;35:387-389.
    PubMed     Text format     Abstract available

  24. BAWDEN SJ, Scott RA, Aithal GP
    Current and Future Magnetic Resonance Technologies for Assessing Liver Disease in Clinical and Experimental Medicine.
    Dig Dis. 2017;35:314-322.
    PubMed     Text format     Abstract available

  25. IREDALE JP, Pellicoro A, Fallowfield JA
    Liver Fibrosis: Understanding the Dynamics of Bidirectional Wound Repair to Inform the Design of Markers and Therapies.
    Dig Dis. 2017;35:310-313.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  26. KIM JK, Kim HD, Jun MJ, Yun SC, et al
    Correction to: Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Oct 13. doi: 10.1007/s10620-017-4785.
    PubMed     Text format     Abstract available

  27. WU W, Liu S, Liang Y, Zhou Z, et al
    Stress Hormone Cortisol Enhances Bcl2 Like-12 Expression to Inhibit p53 in Hepatocellular Carcinoma Cells.
    Dig Dis Sci. 2017 Oct 17. doi: 10.1007/s10620-017-4798.
    PubMed     Text format     Abstract available

  28. GAIDOS JKJ, Fuchs M
    Increased Prevalence of NAFLD in IBD Patients.
    Dig Dis Sci. 2017;62:1362.
    PubMed     Text format    


    Endoscopy

  29. MAHLER MA, Prieto RG, Oria I, Villa-Gomez G, et al
    Single-session EUS-guided hepaticogastrostomy and dual-scope gastroenterostomy: a modified technique for palliative double endoscopic biliary and gastric bypass.
    Endoscopy. 2017 Oct 17. doi: 10.1055/s-0043-119972.
    PubMed     Text format    


    Gastroenterology

  30. CAO W, Chen K, Bolkestein M, Yin Y, et al
    Dynamics of Proliferative and Quiescent Stem Cells in Liver Homeostasis and Injury.
    Gastroenterology. 2017;153:1133-1147.
    PubMed     Text format     Abstract available

  31. HSU EK, Shaffer ML, Gao L, Sonnenday C, et al
    Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List.
    Gastroenterology. 2017;153:988-995.
    PubMed     Text format     Abstract available

  32. CHEN ZH, Yu YP, Tao J, Liu S, et al
    MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.
    Gastroenterology. 2017;153:1120-1132.
    PubMed     Text format     Abstract available


    Hepatology

  33. GUPTA V, Schwartz RE, Shen N, Brown RS Jr, et al
    Hepatology Highlights.
    Hepatology. 2017;66:1367-1369.
    PubMed     Text format    

  34. MIDDLETON MS, Van Natta ML, Heba ER, Alazraki A, et al
    Diagnostic Accuracy of Magnetic Resonance Imaging Hepatic Proton Density Fat Fraction in Pediatric Nonalcoholic Fatty Liver Disease.
    Hepatology. 2017 Oct 13. doi: 10.1002/hep.29596.
    PubMed     Text format     Abstract available


    Indian J Gastroenterol

  35. GHOSHAL UC, Baba CS, Ghoshal U, Alexander G, et al
    Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture.
    Indian J Gastroenterol. 2017 Oct 16. doi: 10.1007/s12664-017-0797.
    PubMed     Text format     Abstract available


    Int J Cancer

  36. GOWING SD, Chow SC, Cools-Lartigue JJ, Chen CB, et al
    Gram-Positive Pneumonia Augments Non-Small Cell Lung Cancer Metastasis Via Host Toll-like Receptor 2 Activation.
    Int J Cancer. 2017 Apr 12. doi: 10.1002/ijc.30734.
    PubMed     Text format     Abstract available


    J Gastroenterol

  37. NAKAO M, Nakayama N, Uchida Y, Tomiya T, et al
    Nationwide survey for acute liver failure and late-onset hepatic failure in Japan.
    J Gastroenterol. 2017 Oct 13. doi: 10.1007/s00535-017-1394.
    PubMed     Text format     Abstract available


    J Hepatol

  38. NAULT JC, Sutter O, Nahon P, Ganne-Carrie N, et al
    Percutaneous treatment of hepatocellular carcinoma: state of the art and innovations.
    J Hepatol. 2017 Oct 12. pii: S0168-8278(17)32351.
    PubMed     Text format     Abstract available


    J Pediatr

  39. BELLATORRE A, Scherzinger A, Stamm E, Martinez M, et al
    Fetal Overnutrition and Adolescent Hepatic Fat Fraction: the Exploring Perinatal Outcomes in Children Study.
    J Pediatr. 2017 Oct 15. pii: S0022-3476(17)31169.
    PubMed     Text format     Abstract available


    PLoS One

  40. WAN X, Liu Y, Zhao Y, Sun X, et al
    Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1alpha-dependent and -independent mechanism.
    PLoS One. 2017;12:e0184213.
    PubMed     Text format     Abstract available

  41. LIU H, Zhang C, Fan X, Duan Y, et al
    Robust phase-retrieval-based X-ray tomography for morphological assessment of early hepatic echinococcosis infection in rats.
    PLoS One. 2017;12:e0183396.
    PubMed     Text format     Abstract available

  42. NIER A, Engstler AJ, Maier IB, Bergheim I, et al
    Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children.
    PLoS One. 2017;12:e0183282.
    PubMed     Text format     Abstract available

  43. TSUDA T, Kaibori M, Hishikawa H, Nakatake R, et al
    Near-infrared fluorescence imaging and photodynamic therapy with indocyanine green lactosome has antineoplastic effects for hepatocellular carcinoma.
    PLoS One. 2017;12:e0183527.
    PubMed     Text format     Abstract available

  44. LEE JY, Shin DW, Oh JW, Kim W, et al
    Non-alcoholic fatty liver disease as a risk factor for female sexual dysfunction in premenopausal women.
    PLoS One. 2017;12:e0182708.
    PubMed     Text format     Abstract available

  45. ALSHAREEDA AT, Sakaguchi K, Abumaree M, Mohd Zin NK, et al
    The potential of cell sheet technique on the development of hepatocellular carcinoma in rat models.
    PLoS One. 2017;12:e0184004.
    PubMed     Text format     Abstract available

  46. KURUVILLA SP, Tiruchinapally G, Crouch AC, ElSayed MEH, et al
    Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model.
    PLoS One. 2017;12:e0181944.
    PubMed     Text format     Abstract available

  47. KULKARNI S, Dolezal JM, Wang H, Jackson L, et al
    Ribosomopathy-like properties of murine and human cancers.
    PLoS One. 2017;12:e0182705.
    PubMed     Text format     Abstract available

  48. WANG L, Feng Y, Ma X, Wang G, et al
    Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis.
    PLoS One. 2017;12:e0182969.
    PubMed     Text format     Abstract available

  49. DING S, Jiang J, Zhang G, Bu Y, et al
    Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats.
    PLoS One. 2017;12:e0183541.
    PubMed     Text format     Abstract available

  50. MA Z, Zhang Y, Li Q, Xu M, et al
    Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1alpha expression and mitochondrial ROS production.
    PLoS One. 2017;12:e0183426.
    PubMed     Text format     Abstract available

  51. DONAIRES FS, Scatena NF, Alves-Paiva RM, Podlevsky JD, et al
    Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
    PLoS One. 2017;12:e0183287.
    PubMed     Text format     Abstract available

  52. JUN BG, Park WY, Park EJ, Jang JY, et al
    A prospective comparative assessment of the accuracy of the FibroScan in evaluating liver steatosis.
    PLoS One. 2017;12:e0182784.
    PubMed     Text format     Abstract available

  53. LI J, Ghazwani M, Liu K, Huang Y, et al
    Regulation of hepatic stellate cell proliferation and activation by glutamine metabolism.
    PLoS One. 2017;12:e0182679.
    PubMed     Text format     Abstract available

  54. JIAO Y, Ding L, Chu M, Wang T, et al
    Effects of cancer-testis antigen, TFDP3, on cell cycle regulation and its mechanism in L-02 and HepG2 cell lines in vitro.
    PLoS One. 2017;12:e0182781.
    PubMed     Text format     Abstract available

  55. GUO H, Wu T, Lu Q, Dong J, et al
    Hepatocellular carcinoma in elderly: Clinical characteristics, treatments and outcomes compared with younger adults.
    PLoS One. 2017;12:e0184160.
    PubMed     Text format     Abstract available

  56. PUENGEL T, Krenkel O, Kohlhepp M, Lefebvre E, et al
    Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury.
    PLoS One. 2017;12:e0184694.
    PubMed     Text format     Abstract available

  57. CHAN SL, Chua APG, Aminkeng F, Chee CBE, et al
    Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.
    PLoS One. 2017;12:e0186200.
    PubMed     Text format     Abstract available

  58. DING L, Wo L, Du Z, Tang L, et al
    Danshen protects against early-stage alcoholic liver disease in mice via inducing PPARalpha activation and subsequent 4-HNE degradation.
    PLoS One. 2017;12:e0186357.
    PubMed     Text format     Abstract available

  59. CICALESE L, Curcuru G, Montalbano M, Shirafkan A, et al
    Hazardous air pollutants and primary liver cancer in Texas.
    PLoS One. 2017;12:e0185610.
    PubMed     Text format     Abstract available

  60. THEIN HH, Qiao Y, Zaheen A, Jembere N, et al
    Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting.
    PLoS One. 2017;12:e0185198.
    PubMed     Text format     Abstract available

  61. KHAN MAH, Ullah R, Rehman A, Rehman L, et al
    Immunolocalization and immunodetection of the excretory/secretory (ES) antigens of Fasciola gigantica.
    PLoS One. 2017;12:e0185870.
    PubMed     Text format     Abstract available

  62. YEH ML, Huang CI, Huang CF, Hsieh MY, et al
    The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma.
    PLoS One. 2017;12:e0184878.
    PubMed     Text format     Abstract available

  63. CHOI YR, Kim JH, Park SJ, Hur BY, et al
    Therapeutic response assessment using 3D ultrasound for hepatic metastasis from colorectal cancer: Application of a personalized, 3D-printed tumor model using CT images.
    PLoS One. 2017;12:e0182596.
    PubMed     Text format     Abstract available

  64. LAMBERT A, Jarlier M, Gourgou Bourgade S, Conroy T, et al
    Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial.
    PLoS One. 2017;12:e0183288.
    PubMed     Text format     Abstract available

  65. KATSANOS K, Kitrou P, Spiliopoulos S, Maroulis I, et al
    Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
    PLoS One. 2017;12:e0184597.
    PubMed     Text format     Abstract available

  66. CHEN CT, Liu CY, Yu YB, Liu CJ, et al
    Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients.
    PLoS One. 2017;12:e0185210.
    PubMed     Text format     Abstract available

  67. AREVALO-HERRERA M, Rengifo L, Lopez-Perez M, Arce-Plata MI, et al
    Complicated malaria in children and adults from three settings of the Colombian Pacific Coast: A prospective study.
    PLoS One. 2017;12:e0185435.
    PubMed     Text format     Abstract available


    Radiology

  68. SEROR O, Nault JC, N'Kontchou G, Sutter O, et al
    Is "Segmentectomy" a Suitable Term to Use in Patients Undergoing Hepatic Segmental 90Y Radioembolization for the Treatment of Hepatocellular Carcinoma Up to 3 cm?
    Radiology. 2017;285:690-691.
    PubMed     Text format    


    Transplantation

  69. O'LEARY JG, Demetris AJ, Philippe A, Freeman R, et al
    Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
    Transplantation. 2017;101:2399-2409.
    PubMed     Text format     Abstract available

  70. WENG J, Li W, Jia X, An W, et al
    Alleviation of Ischemia-Reperfusion Injury in Liver Steatosis by Augmenter of Liver Regeneration Is Attributed to Antioxidation and Preservation of Mitochondria.
    Transplantation. 2017;101:2340-2348.
    PubMed     Text format     Abstract available

  71. YI Z, Mayorga ME, Orman ES, Wheeler SB, et al
    Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.
    Transplantation. 2017 Jun 20. doi: 10.1097/TP.0000000000001851.
    PubMed     Text format     Abstract available

  72. NEKRASOV V, Matsuoka L, Kaur N, Pita A, et al
    Improvement in the Outcomes of MELD >/= 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Transplantation. 2017 Mar 18. doi: 10.1097/TP.0000000000001738.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: